| | Gene | Proteolytic activity | Expression in human tissues | Substrates | Role | References |
| | ADAMTS-1 | + | Liver, endotheliocyte, skeletal muscle, and ovary | Aggrecan, versican | Cancer, atherosclerosis, fibrosis, antiangiogenesis, ovarian function, and stress | [81–89] |
| | ADAMTS-2 | + | Connective tissue, placenta | Procollagen | Ehlers-Danlos syndrome, mesothelioma, and placenta development | [90–93] |
| | ADAMTS-3 | + | Skin, lung, and brain | Procollagen | Dermatosparaxis, osteoarthritis, and lymphangiogenesis | [7, 94, 95] |
| | ADAMTS-4 | + | Heart, lung, skeletal muscle, liver, and kidney | Aggrecan, COMP, and brevican | Glioma, atherosclerosis, arthritis, and tendinopathy | [63, 96–99] |
| | ADAMTS-5 | + | Macrophage, bladder, oesophagus, and heart | Aggrecan, brevican | Arthritis, cancer | [96, 100, 101] |
| | ADAMTS-6 | | | | Tissue repair | [102] |
| | ADAMTS-7 | + | Heart, liver, kidney, and skeletal muscle | COMP, α2M | Arthritis, atherosclerosis, and kidney damage | [14, 42, 70, 103] |
| | ADAMTS-8 | + | Heart, lung, and kidney | Aggrecan | Cancer, atherosclerosis, arthritis, and antiangiogenesis | [63, 104–106] |
| | ADAMTS-9 | + | Heart, lung, and skeletal muscle | Aggrecan, versican | Cancer, atherosclerosis, arthritis, and tissue syndactyly | [107–109] |
| | ADAMTS-10 | | Lens, cartilage, and skin | | Weill-Marchesani syndrome | [110] |
| | ADAMTS-12 | + | Chondrocyte, lung, kidney, and liver | COMP, α2M, and aggrecan | Arthritis, cancer, and normal inflammatory response | [14, 54, 111–113] |
| | ADAMTS-13 | + | Liver, placenta, heart, and skeletal muscle | von Willebrand factor (vWf) | Thrombotic thrombocytopenic purpura | [9] |
| | ADAMTS-14 | + | Collagen-rich tissue, lung, and kidney | Procollagen | Fibrosis, osteoarthritis, tendon disorders, and sclerosis | [114–118] |
| | ADAMTS-15 | + | Kidney, lung, heart, ovary, and stem cells | Aggrecan | Cancer, follicle rupture, myogenesis, and spinal injury | [1, 119–122] |
| | ADAMTS-16 | + | Lung, kidney, ovary, cartilage, and brain | α2M | Cancer, cryptorchidism, and premature ovarian failure | [22, 123–125] |
| | ADAMTS-17 | | Epidermis, brain, heart, liver, lung, and prostate | | Weill-Marchesani syndrome, short stature, and pediatric stroke | [126–128] |
| | ADAMTS-18 | | Lung, kidney, liver, brain, and prostate chondrocyte | | Ocular disease, cancer, stroke, and bone disorders | [129–133] |
| | ADAMTS-19 | | Lung, endothelium, ovary | Aggrecan | Premature ovarian failure, osteosarcomas | [134–137] |
| | ADAMTS-20 | | Ovary, heart, lung, placenta, and testis | Aggrecan | Melanocyte differentiation, pigmentation, and apoptosis | [19, 138] |
|
|